Skip to main content
Top
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Short report

Hepatitis E Virus infection in HIV-infected patients with elevated serum transaminases levels

Authors: Pierre Sellier, Marie-Christine Mazeron, Sophie Tesse, Esma Badsi, John Evans, Jean-Dominique Magnier, Marie-Jose Sanson-Le-Pors, Jean-François Bergmann, Elisabeth Nicand

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Increases in aminotransferases levels are frequently encountered in HIV-positive patients and often remain unexplained. The role in this setting and natural history of hepatitis E in HIV-infected patients are unknown. The aim of the study was to assess HEV infection in HIV-infected patients attending a Parisian hospital, with a current or previous cryptogenic hepatitis.191 plasma samples collected from 108 HIV-infected patients with elevated aminotransferases levels were retrospectively tested for the presence of hepatitis E virus (HEV) infection markers: anti-HEV IgM antibodies, anti-HEV IgG antibodies, anti-HEV IgG avidity index and plasma HEV RNA.One acute infection, documented by positive tests for anti-HEV IgM antibody, low anti-HEV IgG avidity index and plasma HEV RNA (genotype 3e), and three past infections were diagnosed, without any observed case of persistent infection. The acute hepatitis was benign and resolved spontaneously within two weeks. This infection was probably contracted locally. Acute HEV hepatitis can occur in HIV-infected patients but rarely explains cryptogenic hepatitis, at least in an urban HIV population, regardless geographic origin and CD4 counts.
Appendix
Available only for authorised users
Literature
1.
go back to reference Clemente-Casares P, Pina S, Buti M, Jardi R, MartIn M, Bofill-Mas S, Girones R: Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis 2003, 9: 448-54.CrossRefPubMed Clemente-Casares P, Pina S, Buti M, Jardi R, MartIn M, Bofill-Mas S, Girones R: Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis 2003, 9: 448-54.CrossRefPubMed
2.
go back to reference Christensen PB, Engle RE, Hjort C, Homburg KM, Vach W, Georgsen J, Purcell RH: Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 2008, 47: 1026-31. 10.1086/591970PubMedCentralCrossRefPubMed Christensen PB, Engle RE, Hjort C, Homburg KM, Vach W, Georgsen J, Purcell RH: Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 2008, 47: 1026-31. 10.1086/591970PubMedCentralCrossRefPubMed
3.
go back to reference Kamar N, Selves J, Mansuy JM, Ouezzani L, Péron JM, Guitard J, Cointault O, Esposito L, Abravanel F, Danjoux M, Durand D, Vinel JP, Izopet J, Rostaing L: Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008, 358: 811-7. 10.1056/NEJMoa0706992CrossRefPubMed Kamar N, Selves J, Mansuy JM, Ouezzani L, Péron JM, Guitard J, Cointault O, Esposito L, Abravanel F, Danjoux M, Durand D, Vinel JP, Izopet J, Rostaing L: Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008, 358: 811-7. 10.1056/NEJMoa0706992CrossRefPubMed
4.
go back to reference le Coutre P, Meisel H, Hofmann J, Röcken C, Vuong GL, Neuburger S, Hemmati PG, Dörken B, Arnold R: Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009, 58: 699-702. 10.1136/gut.2008.165571CrossRefPubMed le Coutre P, Meisel H, Hofmann J, Röcken C, Vuong GL, Neuburger S, Hemmati PG, Dörken B, Arnold R: Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009, 58: 699-702. 10.1136/gut.2008.165571CrossRefPubMed
5.
go back to reference Colson P, Dhiver C, Gerolami R: Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection. Clin Microbiol Infect 2008, 14: 1176-1180. 10.1111/j.1469-0691.2008.02102.xCrossRefPubMed Colson P, Dhiver C, Gerolami R: Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection. Clin Microbiol Infect 2008, 14: 1176-1180. 10.1111/j.1469-0691.2008.02102.xCrossRefPubMed
6.
go back to reference Renou C, Lafeuillade A, Cadranel JF, Pavio N, Pariente A, Allègre T, Poggi C, Pénaranda G, Cordier F, Nicand E, ANGH: Hepatitis E virus in HIV-infected patients. AIDS 2010, 24: 1493-9. 10.1097/QAD.0b013e32833a29abCrossRefPubMed Renou C, Lafeuillade A, Cadranel JF, Pavio N, Pariente A, Allègre T, Poggi C, Pénaranda G, Cordier F, Nicand E, ANGH: Hepatitis E virus in HIV-infected patients. AIDS 2010, 24: 1493-9. 10.1097/QAD.0b013e32833a29abCrossRefPubMed
7.
go back to reference Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S: Persistent carriage of hepatitis E virus in patients with HIV infection. New Engl Journal Med 2009, 361: 1025-1027. 10.1056/NEJMc0903778CrossRef Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S: Persistent carriage of hepatitis E virus in patients with HIV infection. New Engl Journal Med 2009, 361: 1025-1027. 10.1056/NEJMc0903778CrossRef
8.
go back to reference Dalton HR, Bendall R, Ijaz S, Banks M: Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008, 8: 698-709. 10.1016/S1473-3099(08)70255-XCrossRefPubMed Dalton HR, Bendall R, Ijaz S, Banks M: Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008, 8: 698-709. 10.1016/S1473-3099(08)70255-XCrossRefPubMed
9.
go back to reference Dalton HR, Fellows HJ, Stableforth W, Joseph M, Thurairajah PH, Warshow U, Hazeldine S, Remnarace R, Ijaz S, Hussaini SH, Bendall RP: The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007, 26: 1429-35. 10.1111/j.1365-2036.2007.03504.xCrossRefPubMed Dalton HR, Fellows HJ, Stableforth W, Joseph M, Thurairajah PH, Warshow U, Hazeldine S, Remnarace R, Ijaz S, Hussaini SH, Bendall RP: The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007, 26: 1429-35. 10.1111/j.1365-2036.2007.03504.xCrossRefPubMed
10.
go back to reference Enouf V, Dos Reis G, Guthmann JP, Guerin PJ, Caron M, Marechal V, Nicand E: Validation of single real-time TaqMan PCR assay for the detection and quantitation of four major genotypes of hepatitis E virus in clinical specimens. J Med Virol 2006, 78: 1076-82. 10.1002/jmv.20665CrossRefPubMed Enouf V, Dos Reis G, Guthmann JP, Guerin PJ, Caron M, Marechal V, Nicand E: Validation of single real-time TaqMan PCR assay for the detection and quantitation of four major genotypes of hepatitis E virus in clinical specimens. J Med Virol 2006, 78: 1076-82. 10.1002/jmv.20665CrossRefPubMed
11.
go back to reference Bigaillon C, Tessé S, Lagathu G, Nicand E: Use of hepatitis E IgG avidity for diagnosis of hepatitis E infection. J Virol Methods 2010, 164: 127-30. 10.1016/j.jviromet.2009.11.028CrossRefPubMed Bigaillon C, Tessé S, Lagathu G, Nicand E: Use of hepatitis E IgG avidity for diagnosis of hepatitis E infection. J Virol Methods 2010, 164: 127-30. 10.1016/j.jviromet.2009.11.028CrossRefPubMed
12.
go back to reference Shata MT, Barrett A, Shire NJ, Abdelwahab SF, Sobhy M, Daef E, El-Kamary SS, Hashem M, Engle RE, Purcell RH, Emerson SU, Strickland GT, Sherman KE: Characterization of hepatitis E -specific cell-mediated immune response using IFNγ-ELISPOT assay. J Immunol Methods 2007, 328: 152-161. 10.1016/j.jim.2007.08.014PubMedCentralCrossRefPubMed Shata MT, Barrett A, Shire NJ, Abdelwahab SF, Sobhy M, Daef E, El-Kamary SS, Hashem M, Engle RE, Purcell RH, Emerson SU, Strickland GT, Sherman KE: Characterization of hepatitis E -specific cell-mediated immune response using IFNγ-ELISPOT assay. J Immunol Methods 2007, 328: 152-161. 10.1016/j.jim.2007.08.014PubMedCentralCrossRefPubMed
13.
go back to reference Nair N, Moss WJ, Scott S, Mugala N, Ndhlovu ZM, Lilo K, Ryon JJ, Monze M, Quinn TC, Cousens S, Cutts F, Griffin DE: HIV-1 Infection in Zambian Children Impairs the Development and Avidity Maturation of Measles Virus-Specific Immunoglobulin G after Vaccination and Infection. J Infect Dis 2009, 200: 1031-1038. 10.1086/605648PubMedCentralCrossRefPubMed Nair N, Moss WJ, Scott S, Mugala N, Ndhlovu ZM, Lilo K, Ryon JJ, Monze M, Quinn TC, Cousens S, Cutts F, Griffin DE: HIV-1 Infection in Zambian Children Impairs the Development and Avidity Maturation of Measles Virus-Specific Immunoglobulin G after Vaccination and Infection. J Infect Dis 2009, 200: 1031-1038. 10.1086/605648PubMedCentralCrossRefPubMed
14.
go back to reference Fainboim H, González J, Fassio E, Martínez A, Otegui L, Eposto M, Cahn P, Marino R, Landeira G, Suaya G, Gancedo E, Castro R, Brajterman L, Laplumé H: Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study. J Viral Hepat 1999, 6: 53-7. 10.1046/j.1365-2893.1999.t01-1-6120135.xCrossRefPubMed Fainboim H, González J, Fassio E, Martínez A, Otegui L, Eposto M, Cahn P, Marino R, Landeira G, Suaya G, Gancedo E, Castro R, Brajterman L, Laplumé H: Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study. J Viral Hepat 1999, 6: 53-7. 10.1046/j.1365-2893.1999.t01-1-6120135.xCrossRefPubMed
15.
go back to reference Madejon A, Vispo E, Bottecchia M, Sanchez-Carrillo M, Garcia-Samaniego J, Soriano V: Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat 2009, 16: 895-896. 10.1111/j.1365-2893.2009.01138.xCrossRefPubMed Madejon A, Vispo E, Bottecchia M, Sanchez-Carrillo M, Garcia-Samaniego J, Soriano V: Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations. J Viral Hepat 2009, 16: 895-896. 10.1111/j.1365-2893.2009.01138.xCrossRefPubMed
Metadata
Title
Hepatitis E Virus infection in HIV-infected patients with elevated serum transaminases levels
Authors
Pierre Sellier
Marie-Christine Mazeron
Sophie Tesse
Esma Badsi
John Evans
Jean-Dominique Magnier
Marie-Jose Sanson-Le-Pors
Jean-François Bergmann
Elisabeth Nicand
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-171

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine